Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Cutan Pathol ; 51(6): 403-406, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38419370

ABSTRACT

Cutaneous pseudolymphomas are a wide group of diseases mimicking cutaneous lymphoma. They comprise several skin conditions with different etiopathogenesis, clinical-pathological features, and prognosis, which may occur in the absence of an identifiable trigger factor or after administration of medications or vaccinations, tattoos, infections, or arthropod bites. They present with different manifestations: from solitary to regionally clustered lesions, up to generalized distribution and, in rare cases, erythroderma. They persist variably, from weeks to years, and resolve spontaneously or after antibiotics, but may recur in some cases. CD30+ T-cell pseudolymphomas are characterized by the presence of large, activated lymphoid cells, generally in response to viral infections, arthropod assault reactions, and drug eruptions. Stenotrophomonas maltophilia is a ubiquitous Gram-negative bacillus responsible for opportunistic infections in immunocompromised patients. Infection of intact skin in immunocompetent patients is particularly rare. Here, we report a case of a man presenting an isolated nodule histopathologically mimicking a primary cutaneous CD30+ T-cell lymphoproliferative disorder.


Subject(s)
Lymphoproliferative Disorders , Pseudolymphoma , Stenotrophomonas maltophilia , Humans , Stenotrophomonas maltophilia/isolation & purification , Male , Lymphoproliferative Disorders/pathology , Lymphoproliferative Disorders/microbiology , Lymphoproliferative Disorders/diagnosis , Pseudolymphoma/pathology , Pseudolymphoma/diagnosis , Pseudolymphoma/microbiology , Pseudolymphoma/immunology , Ki-1 Antigen/metabolism , Gram-Negative Bacterial Infections/diagnosis , Gram-Negative Bacterial Infections/microbiology , Gram-Negative Bacterial Infections/pathology , Diagnosis, Differential , T-Lymphocytes/immunology , T-Lymphocytes/pathology , Skin Diseases, Bacterial/pathology , Skin Diseases, Bacterial/diagnosis , Skin Diseases, Bacterial/microbiology , Skin Diseases, Bacterial/immunology , Middle Aged , Immunocompetence
2.
Lupus ; 30(1): 125-133, 2021 Jan.
Article in English | MEDLINE | ID: mdl-33019879

ABSTRACT

Main subtypes of cutaneous lupus erythematosus are represented by acute, subacute cutaneous, intermittent and chronic cutaneous lupus erythematosus. Discoid lupus erythematosus represents the most common phenotype of chronic cutaneous lupus erythematosus. The spectrum of clinical manifestations mirrors that of several and distinct histopathological features. Such variability among different CLE subtypes is also observed at dermoscopy. Dermoscopy is nowadays considered an additional valuable method for skin lesions assessment in general dermatology, following and completing the well-known clinical diagnostic steps, such as medical history and clinical examination. In vivo reflectance confocal microscopy (RCM) is a non-invasive imaging tool able to assess the epidermis and upper dermis producing high resolution (horizontal ∼1.25 µm, vertical ∼5 µm), en face tissue sections used for melanocytic and inflammatory evaluation. In this study, we reported dermoscopic and RCM features about 9 patients affected by subacute and chronic lupus erythematosus retrospectively analyzed.


Subject(s)
Dermoscopy/methods , Lupus Erythematosus, Discoid/pathology , Microscopy, Confocal/methods , Adult , Aged , Biopsy , Female , Humans , Lupus Erythematosus, Discoid/diagnosis , Male , Middle Aged
3.
Immunotherapy ; 12(18): 1287-1292, 2020 12.
Article in English | MEDLINE | ID: mdl-32957824

ABSTRACT

Introduction: We report a case of a young female patient, previously affected by psoriatic arthritis, and treated with adalimumab, who developed a chronic spontaneous urticaria and started a concomitant therapy with omalizumab. Methods & results: A 50% reduction of the Dermatology Life Quality Index (from 7 at baseline to 4 in weeks 12 and 24) and a complete reset of the Urticaria Activity Score for 7 days (from 27 at baseline to 0 in weeks 12 and 24) were recorded. During all treatment with omalizumab, administering of adalimumab was continued. Due to complete control of urticaria symptoms, the patient stopped treatment with omalizumab after 24 weeks. Conclusion: The combination of adalimumab and omalizumab could offer a favorable efficacy and safety profile. The synergistic action of the two biological drugs in reducing systemic inflammation could be responsible for a shorter time to obtain clinical response.


Subject(s)
Adalimumab/therapeutic use , Anti-Allergic Agents/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Omalizumab/therapeutic use , Urticaria/drug therapy , Adult , Drug Therapy, Combination/methods , Female , Humans , Treatment Outcome , Young Adult
4.
Turk Patoloji Derg ; 36(3): 251-255, 2020.
Article in English | MEDLINE | ID: mdl-31960941

ABSTRACT

Uterine leiomyomas are the most common benign tumors of the gynecological tract. Massive lymphocytic infiltration has been reported rarely in uterine leiomyomas and it has been described as a pathogenetic correlation with gonadotropin-releasing hormone agonists. Uterine leiomyomas with massive lymphoid infiltration have to be differentiated from non-Hodgkin lymphomas. We report a case of a woman without a history of gonadotropin-releasing hormone agonist treatment, who presented with a uterine leiomyoma that increased in size after the procedure of assisted in-vitro fertilization, and associated with massive nodular lymphoid infiltrate simulating, morphologically, a non-Hodgkin lymphoma. Uterine leiomyoma with massive lymphocytic infiltration is a very rare entity, probably of reactive significance, which has to be differentiated from diseases that need a systemic therapeutic approach.


Subject(s)
Fertilization in Vitro , Leiomyoma/pathology , Uterine Neoplasms/pathology , Adult , Female , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...